Impact of Resveratrol and Pharmaceutical Care on Type 2 Diabetes Mellitus and Its Neuropathic Complication: A Randomized Placebo Controlled Clinical Trial

Figure 5

Effect of resveratrol with and without pharmaceutical care (PC) on neuropathic symptoms using Michigan neuropathy screening instrument (MSNI-examination) score shown as box and whiskers diagram. Line at median demonstrates MSNI-examination score of the patients with diabetic neuropathic symptoms from day 0 to day 90 of administration of resveratrol and placebo with and without pharmaceutical care. Two-way ANOVA repeated measure-mixed model followed by Tukey’s multiple comparison was used for comparison between different groups. value <0.05 was considered statistically significant. <0.01 and <0.001. # denotes a statistically significant difference with the baseline. A cutoff value of MSNI-examination ≥2.5 consider as abnormal. Resv, resveratrol and PC, pharmaceutical care.